BrightPath BiotherapeuticsLtd. (4594.TSE) Q4 2024 Earnings

8NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-4.24
-3.91
-3.58
-3.24

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

BrightPath BiotherapeuticsLtd. (4594.TSE) will report earnings of for Q4 2024 on November 08, 2024.

0 Comments

Share your thoughts